Co-administration of G-CSF with BM-MSCs produced synergistic beneficial effects by promoting cell proliferation and differentiation of bone marrow stem cells led to early neuronal development, reduction the cerebral infarct size and improved the brain regeneration and functional recovery in an experimental mouse model of cerebral ischemia (39). This evidence concerns the gene CSF3 and brain infarction.